Printer Friendly

Articles from Chain Drug Review (January 20, 2003)

1-68 out of 68 article(s)
Title Author Type Words
'It's time for a little more action'. (Technology). Brief Article 317
'Silent commerce' improves asset use, efficiency. (Technology). 593
Accounting change lifts net earnings at Longs. (Business). 594
Amerisource to leverage full range of capabilities. (RX Retail Pharmacy). 402
Amgen positioned to make substantial gains in 2003. (Biotechnology). 342
An opportunity and a challenge for pharmacy. (Focus). Coopman, Robert 410
Anniversary celebrated by Sav-on. Brief Article 133
Aventis increases flu vaccine production. (RX Retail Pharmacy). 462
Boomers seek means to look, feel young. (Personal Care Appliances). Monks, Richard 822
Bush crafts approach to pediatric tests. (RX Government). 150
Bush Medicare plan has major implications for Rx. 464
Charleston, Simmon join GPhA staff. (Government). Brief Article 261
Consumers ambivalent on role of technology. (RX News). 408
Court negates Maine Rx plan. (Focus). 508
Delaware Medicaid fight ends in compromise. 312
Deodarant. (Beauty Aids Report). 360
Disposable razors. (Beauty Aids Report). 343
Electronic product code the new frontier. (Technology). 1518
Employees win suit against Wal-Mart. Brief Article 267
Eye makeup. (Beauty Aids Report). 351
Face makeup. (Beauty Aids Report). 358
Facial cleansers. (Beauty Aids Report). 366
FDA gets tough on claims for dietary supplements. (Government). 403
FDA okays new indication for Clozaril. (RX Marketplace). Brief Article 133
FDA taps Goodman to head biologics evaluation center. (Biotechnology). Brief Article 220
Focus on demand gives Longs an edge. (Technology). 616
Fragrance. (Beauty Aids Report). 381
Goldstein aims to take Hy & Zel's private. 811
Growth in health care costs shows no signs of abating. (RX Marketplace). 554
Hair coloring. (Beauty Aids Report). 327
Hair conditioners. (Beauty Aids Report). 357
Hair spray. (Beauty Aids Report). 352
Hairstyling/setting gels. (Beauty Aids Report). 367
Hand and body creams and lotions. (Beauty Aids Report). 376
Hypertension study yields surprising results. (RX News). 319
Innovations make pharmacy more efficient. (Technology). 599
Investors take another look at industry. (Biotechnology). Industry Overview 407
Lip makeup. (Beauty Aids Report). 368
Mass. tax on scripts takes effect. 513
Pathmark gets back into black in third quarter. 495
PhRMA weighs in on DTC advertising. (RX Marketplace). 313
Pliva sets sights on generic biotech drugs. (Biotechnology). 358
Power-assisted toothbrushes all the rage. 617
Razor refills. (Beauty Aids Report). 359
Report: computer Rx alerts could be a mixed blessing. (RX News). Brief Article 151
Retailers, suppliers push the envelope. 670
RFID technology fills myriad needs. (Technology). Brief Article 311
Rite Aid putting an old issue to rest. 407
Rite Aid targets diabetes. (Focus). Schultz, John 832
Rite aid turnaround continues to gain momentum. (Business). 1548
Rite Aid upgraded. Brief Article 248
Romanow commission assesses Canadian health care system. (RX Government). 1241
Safeway tabs Hasker Sr. VP. Brief Article 144
Schwarz ships generic version of Prilosec to pharmacies. (Marketplace). Brief Article 185
Shampoo. (Beauty Aids Report). 395
Software maximizes pharmacy reimbursement: online, real-time pre-/post adjudication editing prescription pricing controls centralized management and reporting capabilities. 433
SpectRx introduces line of diabetes care products. (Marketplace). Brief Article 239
Storch succeeds Parrish as president of MSI. 418
Study finds Aranesp less expensive alternative to epoetin alfa. (RX Biotechnology). Brief Article 258
Suntan lotion and oil. (Beauty Aids Report). 371
There's good news and bad in beauty care. (Beauty Aids Report). 672
Tracking trends in Rx care. (Focus). 492
US Bioservices is acquired by Amerisource for $160 mil. (RX News). Brief Article 157
USP begins rolling out DSVP program. (Government). Brief Article 130
Wal-Mart, Giant Eagle ink deals with McKesson. Brief Article 262
Walgreens' history over the past 25 years in microcosm. (My Turn). Pinto, David 1253
Watson will cooperate with Cipla. (RX Marketplace). Brief Article 176
Whitman takes stock after 25 years at NACDS. Woldt, Jeffrey Interview 1626

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters